MoneyWorks4Me

Aurobindo Pharma submits disclosure

18 Jun 2014 Evaluate

Aurobindo Pharma has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1633.45 2.45 (0.15%)
28-Aug-2026 09:53 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1914.00
Dr. Reddys Labs. 1183.05
Cipla 1416.15
Lupin 2160.00
Zydus Lifesciences 1183.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: